Quantcast

Latest Oligonucleotide Stories

2014-07-09 11:26:03

Mary Ann Liebert, Inc. Novel oligonucleotide-based drugs in development offer promising alternatives for treating a range of diseases. A group of industry and regulatory scientists developing these new nucleic acid-based therapies released consensus recommendations for evaluating the pharmacological safety of oligonucleotide therapeutics. The document is published in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available on the...

2014-06-30 12:31:47

DUBLIN, June 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7k9qdg/synthetic_biology) has announced the addition of the "2014 Report on the International Synthetic Biology (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Synthetic biology is a synergistic combination of biology and...

2014-06-23 08:28:39

MILFORD, Mass., June 23, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel drugs to treat a number of medical conditions, with a primary focus in antivirals, today announced two presentations at the Nucleic Acid Summit 2014 held June 19-20, 2014 in San Diego. "The research presented continues to expand our understanding of small molecule nucleic acid hybrids (SMNH) and the underlying...

2014-04-08 12:22:32

ALBANY, New York, April 8, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019" the global synthetic biologymarket was valued at USD 1.8 billion in 2012 and is estimated to reach a market worth of USD 13.4 billion...

2013-09-19 23:37:25

The Oligo Factory, a provider of quality custom DNA/RNA synthesis services, announced plans to expand its facilities to accommodate growing market demand for mg to gram scale custom oligonucleotides, derivatives and modifications. Holliston, MA (PRWEB) September 19, 2013 The Oligo Factory, a provider of quality custom DNA/RNA synthesis services, announced plans to expand its facilities to accommodate growing market demand for mg to gram scale custom oligonucleotides, derivatives and...

2013-08-09 23:03:53

Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy by funding and advancing a comprehensive research program, including drug discovery programs to make practical new therapies. This is the fourth drug discovery project funded by Families of SMA in 2013 with a total investment of $550,000. Elk Grove Village, IL (PRWEB) August 09, 2013 This program will systematically assess the effect of backbone chemistry on the therapeutic efficacy of Antisense...

2013-06-03 13:28:14

A new method of manufacturing short, single-stranded DNA molecules can solve many of the problems associated with current production methods. The new method, which is described in the scientific periodical Nature Methods, can be of value to both DNA nanotechnology and the development of drugs consisting of DNA fragments. The novel technique for manufacturing short, single-stranded DNA molecules — or oligonucleotides — has been developed by researchers at Karolinska Institutet...

2013-05-13 23:25:50

Leading Biotechnology Manufacturer NITTO DENKO Avecia Inc. broadens its offerings with its new OliGrow service Milford, Massachusetts (PRWEB) May 13, 2013 NITTO DENKO Avecia Inc., an industry leader in therapeutic nucleic acid manufacturing and development services, is proud to introduce a new pre-clinical oligonucleotide synthesis service, OliGrow. Combining phase appropriate quality and purity standards with a high level of customer service, the Avecia OliGrow team delivers pre-clinical...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related